The "O" class: crafting clinical care with FoxO transcription factors.
about
Erythropoietin and diabetes mellitusFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusErythropoietin: new directions for the nervous systemOxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy.FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryFOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling.Novel avenues of drug discovery and biomarkers for diabetes mellitus.EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.P. gingivalis modulates keratinocytes through FOXO transcription factors.Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.Translating cell survival and cell longevity into treatment strategies with SIRT1Targeting cardiovascular disease with novel SIRT1 pathways.Lack of association between FOXO1 polymorphisms and bacteremia.Novel directions for diabetes mellitus drug discoveryAnalysis of FOXO1 mutations in diffuse large B-cell lymphomaForkhead transcription factors: new considerations for alzheimer's disease and dementia.FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.FOXO3a inhibits TNF-α- and IL-1β-induced astrocyte proliferation:Implication for reactive astrogliosisIntrinsic role of FoxO3a in the development of CD8+ T cell memory.The vitamin nicotinamide: translating nutrition into clinical care.A fork in the path: Developing therapeutic inroads with FoxO proteins.Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling.Adult Stem Cells and Diseases of Aging.Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes.Knockdown of Sec8 promotes cell-cycle arrest at G1/S phase by inducing p21 via control of FOXO proteins.Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.FOXO3 rs12212067: T > G Association with Active Tuberculosis in Han Chinese Population.Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.FoxO proteins in the nervous system.Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy
P2860
Q26777878-F67D58CE-32BB-4703-9E8B-2D32F063A925Q26800615-CDA2862F-E7BB-4F4A-877B-8B1131E74D54Q26828425-0362A912-0179-4551-9C73-A9A9AF87F0E8Q30630953-DCFDAC8E-DE93-40A7-BC50-AB440E71006CQ33604706-3DBB399F-D37E-4D8F-9B9E-87E1C6CBAEECQ33682262-67769034-4CF5-4997-A9EC-DAD37830F85BQ33717008-3B579425-2865-4F18-8E17-0A200BB52574Q33749358-665547B7-1F53-41BF-B018-5FC357D3DA37Q33802721-80EDE399-7480-4C25-8480-7C4A51DEECF0Q34552287-B88BCC2D-D99A-4DBC-A7DF-B3CC22C41C07Q34887803-2A4DC6B3-126C-4B41-8A1A-078407DC454EQ35050312-F43F25AC-EEF2-4B81-9C37-2C07F8CE3958Q35146283-190D3687-66B0-4FA6-ADCC-E7D47AA22AD8Q35660308-BBD22EC3-9192-4EC5-8CB7-033091CAD5DEQ35661632-AB178D7E-255E-4BC5-A847-61DA5CE9C888Q36317994-F0E635C6-2C10-425F-9F80-E13C72246C1DQ36487424-BD7B3139-FBC3-47E8-B0F2-B86682B79554Q36814631-DF030872-C6D4-4721-B658-7118A074CBA3Q37064987-F3811A1F-3855-4738-9959-2674CF03D88DQ37095415-24F6D508-AA6B-4CCB-B837-AA54279C4692Q37106118-A94D60E9-D31D-4E85-A292-8B822DA4C791Q37273739-C11AC476-8DE9-4202-BDDE-D4C297A16225Q37374047-32E15ADA-272F-4876-A12E-6822EB21B969Q37390262-27651A0E-F12C-4539-91A2-F962791091E2Q37525331-287E0F63-179C-4D11-A746-7F868AFED6EAQ37583050-915BA71F-BB9B-4A99-83B7-E394CF606AD2Q37711264-41660264-A017-49F2-91A4-2B9D7403CF2BQ38294227-8EB6BC74-453A-4CBE-AE19-79D359E62227Q39050385-B1C80ADD-0B2D-4435-A18F-F90BF5822E77Q39477514-5A968FF9-E34F-4019-8AEC-F2B1A63D0C8CQ41083157-D3890887-EED8-4B0A-AEE1-2039BD7C8592Q45305554-3A52508F-63CD-4FB5-9EED-84C0E97080C0Q53622309-67F3BE46-3606-4415-8A94-B49AAD7E36FBQ58724803-C48EABD1-007E-4174-BBF4-0A6629416CEA
P2860
The "O" class: crafting clinical care with FoxO transcription factors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The "O" class: crafting clinical care with FoxO transcription factors.
@ast
The "O" class: crafting clinical care with FoxO transcription factors.
@en
type
label
The "O" class: crafting clinical care with FoxO transcription factors.
@ast
The "O" class: crafting clinical care with FoxO transcription factors.
@en
prefLabel
The "O" class: crafting clinical care with FoxO transcription factors.
@ast
The "O" class: crafting clinical care with FoxO transcription factors.
@en
P2093
P2860
P1476
The "O" class: crafting clinical care with FoxO transcription factors.
@en
P2093
Jinling Hou
Kenneth Maiese
Yan Chen Shang
Zhao Zhong Chong
P2860
P304
P356
10.1007/978-1-4419-1599-3_18
P407
P577
2009-01-01T00:00:00Z